Wong-Chong J, Bernadach M, Ginzac A, Veyssière H, Durando X. Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report. World J Clin Cases 2021; 9(5): 1139-1147 [PMID: 33644178 DOI: 10.12998/wjcc.v9.i5.1139]
Please LOGIN to submit a new comment.